Background: Cutaneous and subcutaneous metastasis from an underlying primary, indicates a dismal outcome for patients. It is appropriate to use fine needle aspiration cytology as a minimally invasive method for diagnosis. This study emphasises the role of fine needle aspiration cytology in diagnosing metastatic skin nodules.
INTRODUCTION
Cutaneous and subcutaneous metastases from an underlying primary is a rare occurrence. 1 Autopsy study based data indicate an approximate range of 0.8-5%. [2] [3] [4] Metastasis can occur at any age, but the incidence rises with advancing age, especially after the fifth decade of life. Skin metastases are believed to be due to systemic spread and they represent terminal stage of malignant disease with limited survival period. 5 As an alternative to performing biopsies, fine needle aspiration cytology (FNAC) is a minimally invasive method, that can be used to diagnose these cases.
FNAC is important in easily accessible and palpable lesions. 40 It is a relatively simple, rapid and inexpensive procedure with high sensitivity and specificity in evaluating these cases. [6] [7] [8] This study emphasises the role of FNAC in diagnosing cutaneous and subcutaneous metastases in cases with known and unknown primaries.
MATERIALS AND METHODS
This was a retrospective study in which the record of all patients subjected to FNAC from April 2008 -Nov 2010 in the department of pathology, Tribhuvan University Teaching Hospital, were reviewed. Of 5,927 patients who underwent aspiration during this period, 19 cases diagnosed as metastatic cutaneous and subcutaneous lesions were included in the study.
Samples were obtained using the conventional method of FNAC. Dry smears were stained by Giemsa and wet smears were prepared by Papanicoloau method.
RESULTS
From 5,927 patients subjected to FNAC, 19 (0.3%) cases were diagnosed as cutaneous/subcutaneous metastases from known or unknown primary site. Common sites of metastasis with regards to sex are displayed on Table 1 . Primary site and FNAC diagnosis in cases with known primary is demonstrated on Table 2 whereas FNAC diagnosis of unknown primary along with site of metastasis is displayed in Table 3 .
DISCUSSION
Cutaneous metastasis is considered a 'grave' sign for majority of the patients with malignancy.
2, 9 Development of such lesions may indicate failure of ongoing therapeutics or recurrence of a cancer assumed to have been previously eradicated or, rarely, it may be the first sign of unsuspected malignant tumour. 10 In our studies, 19 (0.3%) out 5927 cases subjected to The patients were represented by 12 males and 7 females with age range of 40-85 years (mean 63 years) in males and 1.5-76 years (mean 47.3 years) in females. Most of the studies report a higher incidence of cutaneous metastasis in males rather than females. [5] [6] Age ranges in other studies is variable with 2-74 years in one study 5 and 32-89 years in another study 6 .
Cutaneous metastases are mostly multiple and rarely solitary. However in this study, multiple lesions or multiple site involvement was seen in only 4 cases (21%). Sharma et al reported multiple site involvement in 8 (9%) of the cases.
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Spread to regional skin is via lymphatics whereas subsequent spread to distant sites is due to hematogenous spread. 6 Skin metastases usually occur close to the site of primary tumour, that is, chest in lung carcinoma, abdominal wall in gastrointestinal malignancies and lower back in renal carcinomas. 12 Chest and abdomen followed by head and neck are the most common sites of metastases reported in the literature. 8 In this series also, chest and abdomen followed by scalp were the common sites of metastases.
Incidence of tumours metastasizing to skin correlates with the frequency of occurrence of primary malignant tumours in each gender. 8 Other studies have found lung as the common source of primary in males followed by large intestine, melanoma, renal cell carcinoma and carcinoma of the oral cavity. Breast followed by colon, melanoma, lung, ovary and sarcoma have been found to be more common primaries in females. 10, 12 In our study lung was the most common primary both in males (7 cases) and females (4 cases) followed by kidney (2 cases), colon (1 case) and stomach (1 case) in males and breast (1 case) and brain (1 case) in females. Metastasis from the brain was seen in 1.5 year old female with neuroblastoma diagnosed as metastatic small round cell tumour on scalp FNAC. Metastases from haematological malignancy have been noted in other studies.
In 17 cases with known primaries or those who were diagnosed simultaneously at the time of FNAC, cytological features correlated with the primary neoplasm. Adenocarcinoma from various organs was the commonest to metastasized, similar to a study by Bansal et al. 5 Metastatic lesions should be distinguished from primary adnexal tumours and primary squamous cell carcinoma of the skin. Presence of pools of extracellular mucin, signet cells and three dimensional papillae represent metastases rather than primary in case of adenocarcinoma. 11 Metastases is usually located in the deeper dermis and subcutis and they are free from the overlying skin.
Based on this, 2 cases were labelled as metastatic lesions but the primary was unknown at the time of FNAC and the patients were lost to follow up. Immunocytochemistry was not available to us which could have been helpful in identifying the primary. Schwartz reported cutaneous metastases presenting as first sign of malignancy commonly seen with cancers of lung, kidney and ovary. 13 In some studies, cases of cutaneous metastases failed to find primary site even after autopsies.
14-15

CONCLUSION
FNAC can diagnose a variety of skin lesions which may be supportive in diagnosing a metastasis in cases with known primaries or it may offer a clue to underlying malignancy in unsuspected cases.
